Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection.
Neurosciences (Riyadh)
; 26(3): 295-299, 2021 Jul.
Article
in English
| MEDLINE | ID: covidwho-1299749
ABSTRACT
COVID-19 infection displays heterogeneity of clinical manifestations in symptomatic and asymptomatic patients. We report on a child with Miller Fischer syndrome (MFS) and posterior reversible encephalopathy syndrome (PRES) post-COVID-19 infection. An 11-year-old boy presented with vomiting, headache, blurred vision, dysarthria, dysphagia, respiratory failure, muscle weakness, and unsteadiness. He had been exposed to COVID-19 through an asymptomatic elder brother two months prior to his illness. The MRI brain showed findings consistent with PRES and the diagnosis with Miller Fischer variant of the Guillain-Barré syndrome was made. A cerebrospinal fluid analysis revealed cytoalbuminous dissociation, and a nerve conduction velocity study conclusively showed polyneuropathy. A fluoroscopy of the diaphragms found that there was limited movement in both. Although children seem to be less affected by COVID-19 infection, this report highlights on an important neurological complications that can develop in children and its presence should be taken into consideration when diagnosing different forms of Guillain-Barré.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Miller Fisher Syndrome
/
Posterior Leukoencephalopathy Syndrome
/
COVID-19
Type of study:
Case report
/
Cohort study
/
Prognostic study
Topics:
Long Covid
/
Variants
Limits:
Child
/
Humans
/
Male
Language:
English
Journal:
Neurosciences (Riyadh)
Journal subject:
Neurology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS